HAE logo

Haemonetics (HAE) Free Cash Flow

Annual FCF

$115.45 M
-$47.41 M-29.11%

31 March 2024

HAE Free Cash Flow Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly FCF

$39.39 M
+$72.47 M+219.09%

28 September 2024

HAE Quarterly FCF Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM FCF

$20.35 M
-$50.62 M-71.32%

28 September 2024

HAE TTM FCF Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

HAE Free Cash Flow Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-29.1%-56.2%-90.6%
3 y3 years+60.9%+10.1%-37.8%
5 y5 years+186.3%+92.8%-59.8%

HAE Free Cash Flow High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years-29.1%+60.9%-56.2%+197.6%-90.6%at low
5 y5 years-29.1%+186.3%-56.2%+197.6%-90.6%at low
alltimeall time-29.1%+1341.5%-56.2%+197.6%-90.6%+199.8%

Haemonetics Free Cash Flow History

DateAnnualQuarterlyTTM
Sept 2024
-
$39.39 M(-219.1%)
$20.35 M(-71.3%)
June 2024
-
-$33.08 M(-160.8%)
$70.97 M(-38.5%)
Mar 2024
$115.45 M(-29.1%)
-
-
Mar 2024
-
$54.40 M(-234.8%)
$115.45 M(-10.3%)
Dec 2023
-
-$40.36 M(-144.8%)
$128.75 M(-40.6%)
Sept 2023
-
$90.01 M(+689.2%)
$216.68 M(+21.9%)
June 2023
-
$11.40 M(-83.2%)
$177.75 M(+9.1%)
Mar 2023
$162.87 M(+115.0%)
$67.69 M(+42.3%)
$162.87 M(+27.1%)
Dec 2022
-
$47.57 M(-6.9%)
$128.11 M(+10.1%)
Sept 2022
-
$51.08 M(-1570.4%)
$116.31 M(+32.4%)
June 2022
-
-$3.47 M(-110.5%)
$87.88 M(+16.0%)
Mar 2022
$75.75 M(+5.6%)
$32.94 M(-7.9%)
$75.75 M(+131.4%)
Dec 2021
-
$35.77 M(+57.9%)
$32.73 M(-39.2%)
Sept 2021
-
$22.65 M(-245.2%)
$53.88 M(+3.5%)
June 2021
-
-$15.60 M(+54.7%)
$52.05 M(-27.5%)
Mar 2021
$71.77 M(-34.4%)
-$10.09 M(-117.7%)
$71.77 M(-39.0%)
Dec 2020
-
$56.92 M(+173.4%)
$117.61 M(-1.7%)
Sept 2020
-
$20.82 M(+405.7%)
$119.58 M(+0.3%)
June 2020
-
$4.12 M(-88.5%)
$119.20 M(+8.9%)
Mar 2020
$109.46 M(+171.5%)
$35.76 M(-39.3%)
$109.46 M(+35.8%)
Dec 2019
-
$58.89 M(+188.3%)
$80.62 M(+59.2%)
Sept 2019
-
$20.43 M(-463.4%)
$50.65 M(+29.6%)
June 2019
-
-$5.62 M(-181.2%)
$39.09 M(-3.0%)
Mar 2019
$40.32 M(-72.3%)
$6.92 M(-76.1%)
$40.32 M(-43.9%)
Dec 2018
-
$28.92 M(+226.1%)
$71.92 M(-12.1%)
Sept 2018
-
$8.87 M(-301.9%)
$81.83 M(-29.7%)
June 2018
-
-$4.39 M(-111.4%)
$116.45 M(-20.0%)
Mar 2018
$145.55 M(+74.1%)
$38.52 M(-0.8%)
$145.55 M(+15.5%)
Dec 2017
-
$38.82 M(-10.7%)
$125.99 M(+2.0%)
Sept 2017
-
$43.50 M(+76.1%)
$123.47 M(+23.4%)
June 2017
-
$24.70 M(+30.3%)
$100.09 M(+19.7%)
Mar 2017
$83.60 M(+329.6%)
$18.96 M(-47.8%)
$83.60 M(-6.4%)
Dec 2016
-
$36.31 M(+80.5%)
$89.36 M(+46.1%)
Sept 2016
-
$20.12 M(+144.9%)
$61.16 M(+43.3%)
June 2016
-
$8.22 M(-66.8%)
$42.67 M(+119.3%)
Mar 2016
$19.46 M(+292.5%)
$24.72 M(+204.8%)
$19.46 M(-31.4%)
Dec 2015
-
$8.11 M(+398.5%)
$28.36 M(+62.2%)
Sept 2015
-
$1.63 M(-110.8%)
$17.48 M(+31.3%)
June 2015
-
-$15.00 M(-144.6%)
$13.31 M(+168.4%)
Mar 2015
$4.96 M(-92.5%)
$33.62 M(-1315.7%)
$4.96 M(-169.7%)
Dec 2014
-
-$2.77 M(+8.6%)
-$7.11 M(-128.0%)
Sept 2014
-
-$2.54 M(-89.1%)
$25.42 M(-39.8%)
June 2014
-
-$23.35 M(-208.4%)
$42.22 M(-35.9%)
Mar 2014
$65.88 M(+187.8%)
$21.54 M(-27.6%)
$65.88 M(+11.0%)
Dec 2013
-
$29.77 M(+108.9%)
$59.37 M(+55.0%)
Sept 2013
-
$14.25 M(+4496.8%)
$38.31 M(+23.2%)
June 2013
-
$310.00 K(-97.9%)
$31.08 M(+35.8%)
Mar 2013
$22.89 M(-63.2%)
$15.04 M(+72.6%)
$22.89 M(-10.5%)
Dec 2012
-
$8.71 M(+24.0%)
$25.58 M(-21.4%)
Sept 2012
-
$7.02 M(-189.0%)
$32.56 M(-16.3%)
June 2012
-
-$7.89 M(-144.5%)
$38.90 M(-37.4%)
Mar 2012
$62.12 M(-19.1%)
$17.74 M(+13.1%)
$62.12 M(-4.2%)
Dec 2011
-
$15.69 M(+17.4%)
$64.84 M(-24.0%)
Sept 2011
-
$13.37 M(-12.8%)
$85.28 M(-9.1%)
June 2011
-
$15.33 M(-25.1%)
$93.81 M(+22.2%)
Mar 2011
$76.79 M(+3.3%)
$20.46 M(-43.4%)
$76.79 M(-5.9%)
Dec 2010
-
$36.13 M(+65.0%)
$81.59 M(+23.7%)
Sept 2010
-
$21.90 M(-1389.5%)
$65.96 M(-3.2%)
June 2010
-
-$1.70 M(-106.7%)
$68.16 M(-8.3%)
Mar 2010
$74.36 M(+24.0%)
$25.26 M(+23.2%)
$74.36 M(-9.4%)
Dec 2009
-
$20.51 M(-14.9%)
$82.10 M(+8.6%)
Sept 2009
-
$24.10 M(+435.3%)
$75.58 M(+19.9%)
June 2009
-
$4.50 M(-86.4%)
$63.04 M(+5.1%)
Mar 2009
$59.98 M(+201.8%)
$33.00 M(+135.9%)
$59.98 M(+37.5%)
Dec 2008
-
$13.99 M(+21.0%)
$43.61 M(+11.1%)
Sept 2008
-
$11.55 M(+698.5%)
$39.26 M(+111.1%)
June 2008
-
$1.45 M(-91.3%)
$18.59 M(-6.5%)
DateAnnualQuarterlyTTM
Mar 2008
$19.88 M(-52.8%)
$16.62 M(+72.5%)
$19.88 M(+54.3%)
Dec 2007
-
$9.63 M(-205.8%)
$12.88 M(-34.0%)
Sept 2007
-
-$9.11 M(-433.3%)
$19.52 M(-48.1%)
June 2007
-
$2.73 M(-71.6%)
$37.64 M(-10.6%)
Mar 2007
$42.10 M(-13.8%)
$9.62 M(-40.9%)
$42.10 M(-10.8%)
Dec 2006
-
$16.27 M(+80.7%)
$47.21 M(-10.8%)
Sept 2006
-
$9.01 M(+25.1%)
$52.95 M(+4.3%)
June 2006
-
$7.20 M(-51.1%)
$50.76 M(+3.9%)
Mar 2006
$48.84 M(-9.0%)
$14.73 M(-33.1%)
$48.84 M(-6.6%)
Dec 2005
-
$22.01 M(+223.1%)
$52.30 M(+14.8%)
Sept 2005
-
$6.81 M(+29.0%)
$45.57 M(-14.4%)
June 2005
-
$5.28 M(-71.0%)
$53.26 M(-0.8%)
Mar 2005
$53.68 M(-14.7%)
$18.19 M(+19.1%)
$53.68 M(-7.7%)
Dec 2004
-
$15.28 M(+5.3%)
$58.17 M(-14.0%)
Sept 2004
-
$14.51 M(+154.4%)
$67.61 M(-2.2%)
June 2004
-
$5.70 M(-74.9%)
$69.15 M(+9.9%)
Mar 2004
$62.91 M(+107.9%)
$22.69 M(-8.2%)
$62.91 M(+25.1%)
Dec 2003
-
$24.71 M(+54.1%)
$50.28 M(+36.3%)
Sept 2003
-
$16.04 M(-3092.7%)
$36.88 M(+18.1%)
June 2003
-
-$536.00 K(-105.3%)
$31.22 M(+3.2%)
Mar 2003
$30.26 M(+184.5%)
$10.07 M(-11.0%)
$30.26 M(-3.1%)
Dec 2002
-
$11.31 M(+9.0%)
$31.23 M(+117.0%)
Sept 2002
-
$10.38 M(-794.7%)
$14.39 M(+36.3%)
June 2002
-
-$1.49 M(-113.5%)
$10.55 M(-0.8%)
Mar 2002
$10.64 M(-73.8%)
$11.03 M(-299.6%)
$10.64 M(-32.4%)
Dec 2001
-
-$5.53 M(-184.4%)
$15.73 M(-42.4%)
Sept 2001
-
$6.54 M(-563.2%)
$27.29 M(-28.2%)
June 2001
-
-$1.41 M(-108.8%)
$38.00 M(-6.6%)
Mar 2001
$40.67 M(+34.9%)
$16.12 M(+167.0%)
$40.67 M(-13.8%)
Dec 2000
-
$6.04 M(-65.0%)
$47.20 M(+26.0%)
Sept 2000
-
$17.26 M(+1275.0%)
$37.46 M(+20.0%)
June 2000
-
$1.25 M(-94.5%)
$31.20 M(+3.5%)
Mar 2000
$30.15 M(+168.0%)
$22.65 M(-712.2%)
$30.15 M(+38.6%)
Dec 1999
-
-$3.70 M(-133.6%)
$21.75 M(+68.0%)
Sept 1999
-
$11.00 M(+5400.0%)
$12.95 M(+197.8%)
June 1999
-
$200.00 K(-98.6%)
$4.35 M(-61.3%)
Mar 1999
$11.25 M(>+9900.0%)
$14.25 M(-214.0%)
$11.25 M(-60.7%)
Dec 1998
-
-$12.50 M(-620.8%)
$28.60 M(-20.6%)
Sept 1998
-
$2.40 M(-66.2%)
$36.00 M(+71.4%)
June 1998
-
$7.10 M(-77.5%)
$21.00 M(>+9900.0%)
Mar 1998
$0.00(-100.0%)
$31.60 M(-719.6%)
$0.00(-100.0%)
Dec 1997
-
-$5.10 M(-59.5%)
-$20.40 M(+121.7%)
Sept 1997
-
-$12.60 M(-9.4%)
-$9.20 M(+1433.3%)
June 1997
-
-$13.90 M(-224.1%)
-$600.00 K(-105.9%)
Mar 1997
$10.20 M(-70.9%)
$11.20 M(+83.6%)
$10.20 M(+32.5%)
Dec 1996
-
$6.10 M(-252.5%)
$7.70 M(-34.2%)
Sept 1996
-
-$4.00 M(+29.0%)
$11.70 M(-59.9%)
June 1996
-
-$3.10 M(-135.6%)
$29.20 M(-16.8%)
Mar 1996
$35.10 M(-477.4%)
$8.70 M(-13.9%)
$35.10 M(+19.0%)
Dec 1995
-
$10.10 M(-25.2%)
$29.50 M(+76.6%)
Sept 1995
-
$13.50 M(+382.1%)
$16.70 M(+1184.6%)
June 1995
-
$2.80 M(-9.7%)
$1.30 M(-114.0%)
Mar 1995
-$9.30 M(-326.8%)
$3.10 M(-214.8%)
-$9.30 M(-10.6%)
Dec 1994
-
-$2.70 M(+42.1%)
-$10.40 M(+1980.0%)
Sept 1994
-
-$1.90 M(-75.6%)
-$500.00 K(-118.5%)
June 1994
-
-$7.80 M(-490.0%)
$2.70 M(-34.1%)
Mar 1994
$4.10 M(-77.6%)
$2.00 M(-72.2%)
$4.10 M(-21.2%)
Dec 1993
-
$7.20 M(+453.8%)
$5.20 M(-22.4%)
Sept 1993
-
$1.30 M(-120.3%)
$6.70 M(-49.2%)
June 1993
-
-$6.40 M(-306.5%)
$13.20 M(-27.9%)
Mar 1993
$18.30 M(+147.3%)
$3.10 M(-64.4%)
$18.30 M(-34.2%)
Dec 1992
-
$8.70 M(+11.5%)
$27.80 M(+104.4%)
Sept 1992
-
$7.80 M(-700.0%)
$13.60 M(+231.7%)
June 1992
-
-$1.30 M(-110.3%)
$4.10 M(-44.6%)
Mar 1992
$7.40 M
$12.60 M(-329.1%)
$7.40 M(-242.3%)
Dec 1991
-
-$5.50 M(+223.5%)
-$5.20 M(-1833.3%)
Sept 1991
-
-$1.70 M(-185.0%)
$300.00 K(-85.0%)
June 1991
-
$2.00 M
$2.00 M

FAQ

  • What is Haemonetics annual free cash flow?
  • What is the all time high annual FCF for Haemonetics?
  • What is Haemonetics annual FCF year-on-year change?
  • What is Haemonetics quarterly free cash flow?
  • What is the all time high quarterly FCF for Haemonetics?
  • What is Haemonetics quarterly FCF year-on-year change?
  • What is Haemonetics TTM free cash flow?
  • What is the all time high TTM FCF for Haemonetics?
  • What is Haemonetics TTM FCF year-on-year change?

What is Haemonetics annual free cash flow?

The current annual FCF of HAE is $115.45 M

What is the all time high annual FCF for Haemonetics?

Haemonetics all-time high annual free cash flow is $162.87 M

What is Haemonetics annual FCF year-on-year change?

Over the past year, HAE annual free cash flow has changed by -$47.41 M (-29.11%)

What is Haemonetics quarterly free cash flow?

The current quarterly FCF of HAE is $39.39 M

What is the all time high quarterly FCF for Haemonetics?

Haemonetics all-time high quarterly free cash flow is $90.01 M

What is Haemonetics quarterly FCF year-on-year change?

Over the past year, HAE quarterly free cash flow has changed by -$50.62 M (-56.24%)

What is Haemonetics TTM free cash flow?

The current TTM FCF of HAE is $20.35 M

What is the all time high TTM FCF for Haemonetics?

Haemonetics all-time high TTM free cash flow is $216.68 M

What is Haemonetics TTM FCF year-on-year change?

Over the past year, HAE TTM free cash flow has changed by -$196.32 M (-90.61%)